Cargando…
SAR by kinetics for drug discovery in protein misfolding diseases
To develop effective therapeutic strategies for protein misfolding diseases, a promising route is to identify compounds that inhibit the formation of protein oligomers. To achieve this goal, we report a structure−activity relationship (SAR) approach based on chemical kinetics to estimate quantitativ...
Autores principales: | Chia, Sean, Habchi, Johnny, Michaels, Thomas C. T., Cohen, Samuel I. A., Linse, Sara, Dobson, Christopher M., Knowles, Tuomas P. J., Vendruscolo, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187117/ https://www.ncbi.nlm.nih.gov/pubmed/30257937 http://dx.doi.org/10.1073/pnas.1807884115 |
Ejemplares similares
-
Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
por: Staats, Roxine, et al.
Publicado: (2020) -
Structure-Based
Discovery of Small-Molecule Inhibitors
of the Autocatalytic Proliferation of α-Synuclein Aggregates
por: Chia, Sean, et al.
Publicado: (2022) -
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease
por: Habchi, Johnny, et al.
Publicado: (2016) -
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
por: Arosio, Paolo, et al.
Publicado: (2016) -
Proliferation of Tau 304–380 Fragment Aggregates
through Autocatalytic Secondary Nucleation
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2021)